Kishor Mayekar

Array ( [id] => 4349731 [patent_doc_number] => 06214801 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents' [patent_app_type] => 1 [patent_app_number] => 9/117234 [patent_app_country] => US [patent_app_date] => 1999-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 30916 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214801.pdf [firstpage_image] =>[orig_patent_app_number] => 117234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406816 [patent_doc_number] => 06232300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Treatment of HIV by administration of .beta.-D-2\', 3\'-didehydro-2\',3\'-dideoxy-5-fluorocytidine (D4FC)' [patent_app_type] => 1 [patent_app_number] => 9/310823 [patent_app_country] => US [patent_app_date] => 1999-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8593 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232300.pdf [firstpage_image] =>[orig_patent_app_number] => 310823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1326490 [patent_doc_number] => 06602990 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Process for the production of a porous cross-linked polysaccharide gel and its use as a gel filtration media and in chromatography' [patent_app_type] => B1 [patent_app_number] => 09/155995 [patent_app_country] => US [patent_app_date] => 1999-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5999 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602990.pdf [firstpage_image] =>[orig_patent_app_number] => 09155995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589864 [patent_doc_number] => 06482932 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Nucleoside triphosphates and their incorporation into oligonucleotides' [patent_app_type] => B1 [patent_app_number] => 09/301511 [patent_app_country] => US [patent_app_date] => 1999-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 21106 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482932.pdf [firstpage_image] =>[orig_patent_app_number] => 09301511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4174583 [patent_doc_number] => 06083933 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution' [patent_app_type] => 1 [patent_app_number] => 9/294019 [patent_app_country] => US [patent_app_date] => 1999-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4356 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083933.pdf [firstpage_image] =>[orig_patent_app_number] => 294019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4194375 [patent_doc_number] => 06130326 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Monocyclic L-Nucleosides, analogs and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/291903 [patent_app_country] => US [patent_app_date] => 1999-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 39183 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130326.pdf [firstpage_image] =>[orig_patent_app_number] => 291903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1504736 [patent_doc_number] => 06465628 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Process for the synthesis of oligomeric compounds' [patent_app_type] => B1 [patent_app_number] => 09/288679 [patent_app_country] => US [patent_app_date] => 1999-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13368 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 551 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465628.pdf [firstpage_image] =>[orig_patent_app_number] => 09288679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435980 [patent_doc_number] => 06355623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-03-12 [patent_title] => 'Method of treating IBD/Crohn\'s disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage' [patent_app_type] => B2 [patent_app_number] => 09/288344 [patent_app_country] => US [patent_app_date] => 1999-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10977 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355623.pdf [firstpage_image] =>[orig_patent_app_number] => 09288344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187609 [patent_doc_number] => 06150568 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Valiolone, a method of preparing it, and its use to prepare acarbose and voglibose' [patent_app_type] => 1 [patent_app_number] => 9/280454 [patent_app_country] => US [patent_app_date] => 1999-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1611 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150568.pdf [firstpage_image] =>[orig_patent_app_number] => 280454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4306937 [patent_doc_number] => 06252061 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Process for the production of 2-halo-6-aminopurine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/274518 [patent_app_country] => US [patent_app_date] => 1999-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10275 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/252/06252061.pdf [firstpage_image] =>[orig_patent_app_number] => 274518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360626 [patent_doc_number] => 06175005 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Process for the preparation of cyclic ethers containing an o-silylated hydroxyl group' [patent_app_type] => 1 [patent_app_number] => 9/271165 [patent_app_country] => US [patent_app_date] => 1999-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4662 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/175/06175005.pdf [firstpage_image] =>[orig_patent_app_number] => 271165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4241304 [patent_doc_number] => 06090937 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Methods for producing nucleoside derivatives and intermediates therefor' [patent_app_type] => 1 [patent_app_number] => 9/267789 [patent_app_country] => US [patent_app_date] => 1999-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9607 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090937.pdf [firstpage_image] =>[orig_patent_app_number] => 267789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4182618 [patent_doc_number] => 06020325 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Method for inhibiting replication of HIV' [patent_app_type] => 1 [patent_app_number] => 9/264686 [patent_app_country] => US [patent_app_date] => 1999-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2088 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020325.pdf [firstpage_image] =>[orig_patent_app_number] => 264686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409556 [patent_doc_number] => 06265385 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy' [patent_app_type] => 1 [patent_app_number] => 9/101499 [patent_app_country] => US [patent_app_date] => 1999-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8753 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265385.pdf [firstpage_image] =>[orig_patent_app_number] => 101499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4322922 [patent_doc_number] => 06248905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Acyl derivatives of glycosyl-L-ascorbic acid' [patent_app_type] => 1 [patent_app_number] => 9/261160 [patent_app_country] => US [patent_app_date] => 1999-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 12918 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248905.pdf [firstpage_image] =>[orig_patent_app_number] => 261160 [rel_patent_id] =>[rel_patent_doc_number] =>)